🎁 Black Friday: up to 50% off of annual plans
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
5,8489,2454,7692,4082,8803,498
Market Cap Growth
8.55%93.88%98.03%-16.40%-17.67%-46.25%
Enterprise Value
6,0679,0274,5882,4362,7993,183
Last Close Price
41.3765.4534.4919.3726.8733.05

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Forward PE
-140.94140.94140.94140.94140.94
PS Ratio
12.9720.515.75678.1211.9614.38
PB Ratio
116.18183.069.4712.6010.038.36
P/TBV Ratio
129.53204.7610.3913.6111.039.05
P/FCF Ratio
--30.40---
P/OCF Ratio
--26.56---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
EV/Sales Ratio
13.4620.025.53686.0211.6313.09
EV/EBITDA Ratio
--37.52---
EV/EBIT Ratio
--46.65---
EV/FCF Ratio
--29.25---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Debt / Equity Ratio
27.8727.871.464.461.340.20
Debt / EBITDA Ratio
--5.29---
Debt / FCF Ratio
--4.68---
Net Debt / Equity Ratio
4.334.33-0.360.91-0.04-0.69
Net Debt / EBITDA Ratio
-0.32-0.32-1.50-0.300.061.71
Net Debt / FCF Ratio
-0.77-0.77-1.17-0.290.041.52
Asset Turnover
0.290.290.660.000.330.35
Quick Ratio
3.923.924.736.573.752.67
Current Ratio
4.144.144.866.743.952.92
Return on Equity (ROE)
-258.93%-258.93%8.67%-254.98%-59.33%-42.68%
Return on Assets (ROA)
-28.30%-28.30%4.87%-39.43%-17.58%-15.91%
Return on Invested Capital (ROIC)
-273.74%-240.24%16.78%-187.71%-101.05%-180.86%
Return on Capital Employed (ROCE)
-49.60%-49.60%8.30%-58.00%-31.10%-32.30%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Earnings Yield
-12.36%-7.83%-0.03%-24.90%-7.13%-5.03%
FCF Yield
-4.86%-3.07%3.29%-25.10%-11.48%-5.40%
Buyback Yield / Dilution
-5.89%-5.89%-11.67%-12.21%-1.26%-1.62%
SEC Filings: 10-K · 10-Q